Literature DB >> 8809461

Current status of poliovirus infections.

J L Melnick1.   

Abstract

Two scientists who played leading roles in the conquest of poliomyelitis died recently. In 1954, Jonas Salk provided the first licensed polio vaccine, the formalin (and heat)-inactivated virus. Albert Sabin gave us the attenuated live virus vaccine, which was licensed in 1962. This paper takes the reader through the history of the disease, including its pathogenesis, epidemiology, vaccines, and future directions. The emphasis is on vaccines, for it seems that with proper vaccination the number of new cases is falling dramatically. It is hoped that by the year 2000, we will accomplish the goal of the World Health Organization of "a world without polio." Then, because there is no animal reservoir, we can seriously discuss when and how to eliminate the need for vaccination and ultimately destroy our stocks of poliovirus.

Entities:  

Mesh:

Year:  1996        PMID: 8809461      PMCID: PMC172894          DOI: 10.1128/CMR.9.3.293

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  19 in total

1.  Problems associated with the use of live poliovirus vaccine.

Authors:  J L MELNICK
Journal:  Am J Public Health Nations Health       Date:  1960-07

2.  Poliomyelitis: its highly invasive nature and narrow stream of infection in a community of high socioeconomic level.

Authors:  J P NOLAN; B H WILMER; J L MELNICK
Journal:  N Engl J Med       Date:  1955-12-01       Impact factor: 91.245

3.  Antibodies to three different antigenic types of poliomyelitis virus in sera from North Alaskan Eskimos.

Authors:  J R PAUL; J T RIORDAN; J L MELNICK
Journal:  Am J Hyg       Date:  1951-09

4.  Immune responses in human volunteers upon oral administration of a rodent-adapted strain of poliomyelitis virus.

Authors:  H KOPROWSKI; G A JERVIS; T W NORTON
Journal:  Am J Hyg       Date:  1952-01

5.  Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice.

Authors:  S Abe; Y Ota; S Koike; T Kurata; H Horie; T Nomura; S Hashizume; A Nomoto
Journal:  Virology       Date:  1995-02-01       Impact factor: 3.616

6.  Successful results of a program combining live and inactivated poliovirus vaccines to control poliomyelitis in Gaza.

Authors:  E E Lasch; Y Abed; K Abdulla; A G El Tibbi; O Marcus; M El Massri; R Handscher; C B Gerichter; J L Melnick
Journal:  Rev Infect Dis       Date:  1984 May-Jun

7.  Human poliovirus receptor gene expression and poliovirus tissue tropism in transgenic mice.

Authors:  R Ren; V R Racaniello
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

Review 8.  Environmental virology: from detection of virus in sewage and water by isolation to identification by molecular biology--a trip of over 50 years.

Authors:  T G Metcalf; J L Melnick; M K Estes
Journal:  Annu Rev Microbiol       Date:  1995       Impact factor: 15.500

Review 9.  Poliomyelitis control in Israel, the West Bank and Gaza Strip: changing strategies with the goal of eradication in an endemic area.

Authors:  N Goldblum; C B Gerichter; T H Tulchinsky; J L Melnick
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

10.  Studies on variants of poliomyelitis virus. I. Experimental segregation and properties of avirulent variants of three immunologic types.

Authors:  A B SABIN; W A HENNESSEN; J WINSSER
Journal:  J Exp Med       Date:  1954-06-01       Impact factor: 14.307

View more
  22 in total

1.  Poliomyelitis: historical facts, epidemiology, and current challenges in eradication.

Authors:  Man Mohan Mehndiratta; Prachi Mehndiratta; Renuka Pande
Journal:  Neurohospitalist       Date:  2014-10

2.  IVIG treatment in post-polio patients: evaluation of responders.

Authors:  Gunilla Ostlund; Lisbet Broman; Lars Werhagen; Kristian Borg
Journal:  J Neurol       Date:  2012-05-17       Impact factor: 4.849

3.  History of polio vaccination.

Authors:  Anda Baicus
Journal:  World J Virol       Date:  2012-08-12

Review 4.  Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Muir; U Kämmerer; K Korn; M N Mulders; T Pöyry; B Weissbrich; R Kandolf; G M Cleator; A M van Loon
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

5.  Genomic analysis of vaccine-derived poliovirus strains in stool specimens by combination of full-length PCR and oligonucleotide microarray hybridization.

Authors:  Majid Laassri; Eugenia Dragunsky; Joan Enterline; Tatiana Eremeeva; Olga Ivanova; Kathleen Lottenbach; Robert Belshe; Konstantin Chumakov
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

6.  Genomic analysis of recombinant sabin clinical isolates.

Authors:  Eleni Paximadi; Ioannis Karakasiliotis; Zissis Mamuris; Constantinos Stathopoulos; Vassilis Krikelis; Panayotis Markoulatos
Journal:  Virus Genes       Date:  2006-04       Impact factor: 2.332

7.  Overcoming T cell-mediated immunopathology to achieve safe RSV vaccination.

Authors:  Elaine M Castilow; Steven M Varga
Journal:  Future Virol       Date:  2008       Impact factor: 1.831

8.  Enterovirus Infection Induces Massive Recruitment of All Isoforms of Small Cellular Arf GTPases to the Replication Organelles.

Authors:  Seyedehmahsa Moghimi; Ekaterina Viktorova; Anna Zimina; Tomasz Szul; Elizabeth Sztul; George A Belov
Journal:  J Virol       Date:  2020-12-22       Impact factor: 5.103

9.  Mechanism of action at the molecular level of the antiviral drug 3(2H)-isoflavene against type 2 poliovirus.

Authors:  Anna L Salvati; Alessandra De Dominicis; Sabrina Tait; Andrea Canitano; Armin Lahm; Lucia Fiore
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

10.  New recognition of Enterovirus infections in bottlenose dolphins (Tursiops truncatus).

Authors:  Hendrik H Nollens; Rebecca Rivera; Gustavo Palacios; James F X Wellehan; Jeremiah T Saliki; Shannon L Caseltine; Cynthia R Smith; Eric D Jensen; Jeffrey Hui; W Ian Lipkin; Pamela K Yochem; Randall S Wells; Judy St Leger; Stephanie Venn-Watson
Journal:  Vet Microbiol       Date:  2009-06-06       Impact factor: 3.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.